Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori Eradication
Background. The decline of Helicobacter pylori (H. pylori) eradication rates with standard triple therapy resulted in a search for novel therapies for first-line therapy of H. pylori infection. Aim. The aim of the study is to compare the efficacy of concomitant therapy with sequential therapy as the...
Main Authors: | Sung Min Jung, Dae Young Cheung, Jin Il Kim, Il Kim, Hyeonjin Seong |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2016/1293649 |
Similar Items
-
Concomitant or Sequential Therapy as the First-line Therapy for Eradication of Helicobacter pylori Infection in Korea: A Systematic Review and Meta-analysis
by: Hyun Jin Bae, et al.
Published: (2018-01-01) -
Efficacy of Ecabet Sodium for Helicobacter pylori Eradication with Sequential Therapy
by: Seol So, et al.
Published: (2018-09-01) -
First-line Helicobacter pylori Eradication with Standard Triple Therapy and Concomitant Therapy: A Retrospective Study
by: Moon Won Lee, et al.
Published: (2018-06-01) -
The Efficacy of Rebamipide or Ecabet Sodium Supplementation for Helicobacter pylori Eradication Therapy Compared with Quadruple (Concomitant) Regimen
by: Joonhwan Kim, et al.
Published: (2018-04-01) -
Helicobacter pylori Eradication Therapy and Gastric Cancer Prevention
by: Il Ju Choi
Published: (2018-11-01)